Parkinson's Disease Supplements & Neuroprotection Developments in Treatment of Parkinson’s Disease January 11, 2017 | Leave a Comment This past year brought several exciting developments in the treatment of Parkinson’s disease. From fast-tracking of an antibody being trialed as an immunotherapy drug in cancer treatment to FDA approval of the first medication to treat PD psychosis, researchers are advancing new medications for motor and secondary symptoms of the disease and gaining greater understanding of and potential therapies to slow disease process. Read more » Parkinson's research new parkinson's treatments Nuplazid LAG3 PD medications PD psychosis